Establishment and biological characteristics of human multiple myeloma cell line CZ-1

Chinese Medical Journal

Volumn 117, Issue 1, 2004, Pages 115-119

  Hou, Jian ^a   Lin, Fan Ying ^a   Zhang, Bo ^a   Zhang, Ling Zhen ^a   Ding, Si Qi ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biological characteristics; Cell line; Multiple myeloma

Indexed keywords

ACID PHOSPHATASE; ALPHA4 INTEGRIN; CD19 ANTIGEN; CD2 ANTIGEN; CD28 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; FAS ANTIGEN; FAS LIGAND; HERMES ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MYELOPEROXIDASE; SYNDECAN 1; VIRUS DNA;

ADULT; ADVANCED CANCER; ARTICLE; BLAST CELL; BLOOD; BONE MARROW; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SECRETION; CELL STRUCTURE; CELL SURVIVAL; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 1Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CONTROLLED STUDY; CULTURE MEDIUM; CYTOCHEMISTRY; DNA DETERMINATION; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GIEMSA STAIN; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; PLASMA CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION;

EID: 1242351832     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Matsuoka Y, Moore GE, Yage Y, et al. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med 1967;125:1246-1250.
2. Drexler HG, Matsuoka Y. Malignant hematopoietic cell lines: in vivo models for the study of multiple myeloma and plasma cell leukemia. Leuk Res 2000;24:681-703.
3. Zhang HJ, Guo R. Establishments of three human multiple myeloma cell lines. Cell Biol J 1998;2:88.
4. Zhang XG, Gaillard JP, Robillard N, et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 1994;83: 3654-3663.
5. Matsuo Y, Drexler HG, Nishizake C, et al. Human bone marrow stromal-dependent cell line, MOLP-5, derived from a patient in leukemia of multiple myeloma. Br J Haematol 2000;109:54-63.
6. Uchiyama H, Barut BA, Mohrbacher AF, et al. Adhesion of human myeloma - derived cell lines to bone marrow stromal cells stimulates interleukein-6 secretion. Blood 1993; 82: 3712-3720.
7. Charuhan D, Uchiyama H, Akbarali Y, et al. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood 1996;87:1104-1112.
8. Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993;81:2658-2663.
9. 40 antibody binding modulates human multiple myeloma clongenicity in vivo. Blood 1994;84:3026-3033.
10. 40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 1995;85:1903-1912.
11. Portier M, Moles JP, Mazars GR, et al. P53 and RAS gene mutations in multiple myeloma. Oncogene 1992; 7: 2539-2543.
12. Feinman R, Sawyer J, Hardin J, et al. Cytogenetics and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am 1997;11:21-25.
13. Pérez-Simón JA, Garcia-Sanz R, Tabernero MD, et al. Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes. Blood 1998;91:3366-3371.